MERCAPTOPURINE ANHYDROUS
Anaplastic Glioma of Brain
M.D. Anderson Cancer CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Anaplastic Glioma of Brain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lomustine M.D. Anderson Cancer Center | Phase 2 | B |
THIOGUANINE ANHYDROUS M.D. Anderson Cancer Center | Phase 2 | B |
Eloxatin M.D. Anderson Cancer Center | Phase 2 | B |
METHOTREXATE M.D. Anderson Cancer Center | Phase 2 | B |
Capecitabine M.D. Anderson Cancer Center | Phase 2 | B |
Dfn-15 M.D. Anderson Cancer Center | Phase 2 | B |
Same molecule, other indications
MERCAPTOPURINE ANHYDROUS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →